| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/04/2008 | US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 02/28/2008 | WO2008024298A1 Bis(thiohydrazide amides) for inhibiting angiogenesis |
| 02/28/2008 | WO2008023847A1 P2x4 receptor antagonist |
| 02/28/2008 | WO2008023783A1 Amine compound |
| 02/28/2008 | WO2008023725A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 02/28/2008 | WO2008023455A1 Tyrosinase inhibitor |
| 02/28/2008 | WO2008023258A1 Piperidine derivatives |
| 02/28/2008 | WO2007045450A3 Use of fructanases in feed of hoofed animals to treat and prevent laminitis |
| 02/28/2008 | US20080051464 Protein phosphatase inhibitors |
| 02/28/2008 | US20080051462 Methods for treating genetically-defined proliferative disorders with HSP90 inhibitors |
| 02/28/2008 | US20080051441 Aryl Sulphonamide Modulators |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051429 Use of 4-amino-piperidines for treating sleep disorders |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051414 Protein Kinase Inhibitors |
| 02/28/2008 | US20080051410 Protein Kinase Targeted Therapeutics |
| 02/28/2008 | US20080051403 Treatment For Alzheimer's Disease And Related Conditions |
| 02/28/2008 | US20080051394 6H-Oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 02/28/2008 | US20080051393 Novel cannabinoids and methods of use |
| 02/28/2008 | US20080051386 Tricyclic Pyrazole Derivatives as Cannabinoid Receptor Modulators |
| 02/28/2008 | US20080051373 Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 02/28/2008 | US20080051360 Pkc ligands and polynucleotides encoding pkc ligands |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051348 Treatment of infections and other disorders |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051342 TRPS1-mediated modulation of hair growth |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080051322 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors |
| 02/28/2008 | US20080051320 S-nitrosoprotein preparation and production method therefor |
| 02/28/2008 | US20080051315 Grp Receptor-Related Methods for the Treating and Preventing Fear-Related Disorders |
| 02/28/2008 | US20080050716 Methods for preserving organs and tissues |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050457 Ginkgo Biloba Extract And Method For Producing The Same |
| 02/28/2008 | US20080050447 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080050446 Fast Release Dosage Forms for Antibiotics |
| 02/28/2008 | US20080050427 Analgesic combination of tramadol and meloxicam |
| 02/28/2008 | US20080050424 Transdermal therapeutic system for treating parkinsonism |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050416 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 02/28/2008 | US20080050415 Polymeric/ceramic composite materials for use in medical devices |
| 02/28/2008 | US20080050395 Methods for preparing and delivering adjuvant compositions |
| 02/28/2008 | US20080050387 Non-Androgen Dependent Roles for Androgen Receptor and Non-Androgen Related Inhibitors of Androgen Receptor |
| 02/28/2008 | US20080050384 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/28/2008 | US20080050382 Granulysin and uses thereof |
| 02/28/2008 | US20080050380 Glycoprotein VI and uses thereof |
| 02/28/2008 | US20080050379 Cancer gene determination and therapeutic screening using signature gene sets |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050364 Treatment of LFA-1 Associated Disorders with Increasing Doses of LFA-1 Antagonist |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050361 Staphylococcus aureas specific anti-infectives |
| 02/28/2008 | US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 02/28/2008 | US20080050356 Liquefying a vitreous and/or inducing posterior vitreous detachment of an eye via microplasmin injection; treating vision defects; preventing or reducing the risk of retinal detachment |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050342 Genetic inhibition by double-stranded RNA |
| 02/28/2008 | US20080050340 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 02/28/2008 | US20080050337 Method for using calcium-sensitive potassium channel agonist for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 02/28/2008 | US20080050312 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 02/28/2008 | US20080050311 Monoclonal Antibody hPAM4 |
| 02/28/2008 | CA2661187A1 Piperidine derivatives |
| 02/28/2008 | CA2661054A1 Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1892238A1 1, 2-di(cyclic group)substituted benzene derivative |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891971A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 02/27/2008 | EP1891970A1 Beta glucan-based vaccines free of mannoprotein |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891948A1 Treatment of neurological and neuropsychological disorders |
| 02/27/2008 | EP1890729A2 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
| 02/27/2008 | EP1558610B1 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1506958B1 Process for producing shogaol and intermediates for the synthesis thereof |
| 02/27/2008 | EP1506192B1 Substituted pyrroline kinase inhibitors |
| 02/27/2008 | EP1496873B1 Chewable soft capsule |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1471065B1 Novel 1,2,4-triazole compound |
| 02/27/2008 | EP1458364B1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1341811B1 Orally ingestible preparation of mistletoe lectins and method |
| 02/27/2008 | EP1318994B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1246806B1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | EP1149105B1 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 02/27/2008 | EP1141278B1 Therapeutic pde4d phosphodiesterase inhibitors |
| 02/27/2008 | EP1089740B1 Compositions for the treatment of cdad initiated by c. difficile toxin b |
| 02/27/2008 | EP1039906B1 metal complexes with antibacterian and fungicidal effects |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN101133043A Method of producing proanthocyanidin oligomer |
| 02/27/2008 | CN101133037A 6-membered heterocyclic compound and use thereof |
| 02/27/2008 | CN101130733A Wine capable of changing acidic constitution of human body |
| 02/27/2008 | CN101130567A Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |